Acute kidney injury (AKI) occurs in about half of critically ill patients and is associated with
high in-hospital mortality, increased long-term mortality postdischarge, and subsequent …

The gut microbiome influences host physiology and pathophysiology through several
pathways, one of which is microbial production of chemical metabolites which interact with …

Antibiotics have been widely detected in the water environment and thus pose a potential
threat to human health. Although antibiotics have health-promoting properties, whether and …

Gut microbiome research has increased dramatically in the last decade, including in renal
health and disease. The field is moving from experiments showing mere association to …

In recent years, the clinical impact of intestinal microbiota–kidney interaction has been
emerging. Experimental evidence highlighted a bidirectional evolutionary correlation …

There is increasing interest in the therapeutic potential of manipulating the gut microbiome
of patients with chronic kidney disease (CKD). This is because there is a substantial …

Acute kidney injury (AKI) is a common and serious disease entity that affects native kidneys
and allografts but for which no specific treatments exist. Complex intrarenal inflammatory …

Background Vancomycin (VCM) has long been used clinically to fight against Gram-positive
bacterial infections. In recent decades, an increased number of kidney injury cases caused …

Intestinal microbiota and their metabolites affect systemic inflammation and kidney disease
outcomes. Here, we investigated the key metabolites associated with the acute kidney injury …

Ischemic acute kidney injury (AKI) is a common medical problem with significant mortality
and morbidity, affecting a large number of patients globally. Ischemic AKI is associated with …